BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34104376)

  • 21. Patients' experiences of engaging with electronic Patient Reported Outcome Measures (PROMs) after the completion of radiation therapy for breast cancer: a pilot service evaluation.
    Hughes J; Flood T
    J Med Radiat Sci; 2023 Dec; 70(4):424-435. PubMed ID: 37550951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of electronic patient-reported outcome measures in cystic fibrosis research: Application to the GALAXY study.
    Sathe M; Moshiree B; Vu PT; Khan U; Heltshe SL; Romasco M; Freedman SD; Schwarzenberg SJ; Goss CH; Freeman AJ
    J Cyst Fibros; 2021 Jul; 20(4):605-611. PubMed ID: 34305007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilising Electronic PROMs to Measure a Change in Health Following Elective Laparoscopic Cholecystectomy: A Feasibility Study.
    Daliya P; Lobo DN; Parsons SL
    World J Surg; 2022 Sep; 46(9):2155-2165. PubMed ID: 35610385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol.
    Kyte D; Bishop J; Brettell E; Calvert M; Cockwell P; Dutton M; Eddington H; Hadley G; Ives NJ; Jackson LJ; Stringer S; Valente M
    BMJ Open; 2018 Oct; 8(10):e026080. PubMed ID: 30373785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using ePROMs for follow-up after palliative radiotherapy: An exploratory study with patients and health care providers.
    Oldenburger E; Neyens I; Coolbrandt A; Isebaert S; Sevenants A; Van Audenhove C; Haustermans K
    Patient Educ Couns; 2022 Jul; 105(7):2355-2361. PubMed ID: 34949467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective application of implementation science theories and frameworks to inform use of PROMs in routine clinical care within an integrated pain network.
    Ahmed S; Zidarov D; Eilayyan O; Visca R
    Qual Life Res; 2021 Nov; 30(11):3035-3047. PubMed ID: 32876812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of patient-reported outcomes for symptom management in oncology practice through the SIMPRO research consortium: a protocol for a pragmatic type II hybrid effectiveness-implementation multi-center cluster-randomized stepped wedge trial.
    Hassett MJ; Wong S; Osarogiagbon RU; Bian J; Dizon DS; Jenkins HH; Uno H; Cronin C; Schrag D;
    Trials; 2022 Jun; 23(1):506. PubMed ID: 35710449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of electronic patient-reported outcome measures on patients' perception of the physician - the randomized ePREFERENCE study.
    Gani C; Bickenbach P; Tenev A; Niyazi M; Festl-Wietek T; Herrmann-Werner A
    Radiother Oncol; 2024 May; 194():110192. PubMed ID: 38428640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An implementation study of electronic assessment of patient-reported outcomes in inpatient radiation oncology.
    Nordhausen T; Lampe K; Vordermark D; Holzner B; Al-Ali HK; Meyer G; Schmidt H
    J Patient Rep Outcomes; 2022 Jul; 6(1):77. PubMed ID: 35852715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilizing Digital Health to Collect Electronic Patient-Reported Outcomes in Prostate Cancer: Single-Arm Pilot Trial.
    Tran C; Dicker A; Leiby B; Gressen E; Williams N; Jim H
    J Med Internet Res; 2020 Mar; 22(3):e12689. PubMed ID: 32209536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The administration of the paper and electronic versions of the Manual Ability Measure-36 (MAM-36) and Fatigue Severity Scale (FSS) is equivalent in people with multiple sclerosis.
    Tacchino A; Di Giovanni R; Grange E; Spirito MM; Ponzio M; Battaglia MA; Brichetto G; Solaro CM
    Neurol Sci; 2024 Mar; 45(3):1155-1162. PubMed ID: 37828384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient and clinician opinions of patient reported outcome measures (PROMs) in the management of patients with rare diseases: a qualitative study.
    Aiyegbusi OL; Isa F; Kyte D; Pankhurst T; Kerecuk L; Ferguson J; Lipkin G; Calvert M
    Health Qual Life Outcomes; 2020 Jun; 18(1):177. PubMed ID: 32522194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-reported MeasUrement of Physical and PsychosOcial Symptoms Response Tool (SUPPORT-dialysis): systematic symptom assessment and management in patients on in-centre haemodialysis - a parallel arm, non-randomised feasibility pilot study protocol.
    Gill JK; Pucci M; Samudio A; Ahmed T; Siddiqui R; Edwards N; Marticorena RM; Donnelly S; Lok C; Wentlandt K; Wolofsky K; Mucsi I
    BMJ Open; 2024 Jan; 14(1):e080712. PubMed ID: 38296283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of Tablet-Based Patient-Reported Symptom Data Collection Among Hemodialysis Patients.
    Flythe JE; Tugman MJ; Narendra JH; Dorough A; Hilbert J; Assimon MM; DeWalt DA
    Kidney Int Rep; 2020 Jul; 5(7):1026-1039. PubMed ID: 32647760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Embedding electronic patient-reported outcome measures into routine care for patients with stage III MELanoma (ePROMs-MEL): protocol for a prospective, longitudinal, mixed-methods pilot study.
    Dempsey K; Saw R; Bartula I; Lo S; Lawn C; Pennington T; Spillane A; Boyle F; Dong S; Dieng M; Milne D; Seaman L; Saks D; Lai-Kwon J; Thompson JR; Morton R
    BMJ Open; 2022 Dec; 12(12):e066852. PubMed ID: 36600423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare provider characteristics that influence the implementation of individual-level patient-centered outcome measure (PROM) and patient-reported experience measure (PREM) data across practice settings: a protocol for a mixed methods systematic review with a narrative synthesis.
    Wolff AC; Dresselhuis A; Hejazi S; Dixon D; Gibson D; Howard AF; Liva S; Astle B; Reimer-Kirkham S; Noonan VK; Edwards L
    Syst Rev; 2021 Jun; 10(1):169. PubMed ID: 34108024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Key methodological considerations for usability testing of electronic patient-reported outcome (ePRO) systems.
    Aiyegbusi OL
    Qual Life Res; 2020 Feb; 29(2):325-333. PubMed ID: 31691202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementing patient-reported outcomes into routine care: an audit of cancer patients from two local health districts in New South Wales to understand their capabilities and preferences.
    Bamgboje-Ayodele A; Arnold B; Durcinoska I; Avery S; Vinod S; Rincones O; Thomas T; Descallar J; Smith B; Delaney GP; Girgis A
    Aust Health Rev; 2022 Jun; 46(3):331-337. PubMed ID: 35545809
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.